CMS Open Payments · Program Year 2024
Ortho-Clinical Diagnostics, Inc.
Ortho-Clinical Diagnostics, Inc. reported $10,686,573.34 across General Payments, Research, and Ownership to 232 physicians and teaching hospitals across 666 transactions.
- $10.7M Top 10% payer
- All-tracks total
- 666 Above-median volume
- Transactions
- 232 Above-median reach
- Recipients
- +$1.0M
- General Payments vs PY2023
Ortho-Clinical Diagnostics, Inc. reported $10,686,573.34 across all CMS Open Payments tracks (General + Research + Ownership) to 232 physicians and teaching hospitals in Program Year 2024 - ranking #162 of 1,925 reporting manufacturers (0.1% of the all-tracks industry total); General Payments alone were $1,139,174.94, averaging $46.1K per recipient.
How Ortho-Clinical Diagnostics, Inc.'s $10.7M all-tracks total breaks down
Ortho-Clinical Diagnostics, Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
D
51/100
Total payments
A
100/100
Transaction volume
F
15/100
Physician reach
F
12/100
Payment type diversity
C
77/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer ortho-clinical-diagnostics-inc Ortho-Clinical Diagnostics, Inc.
$10.7M · #162/1,925 · 0.1% industry · PY2024
- TOT $10.7M
- RANK #162
- SHARE 0.1%
- TXN 666
- RCP 232
- CAT 6
- GEN $1.1M
- ΔGEN +$1.0M
- TOP1 28.8%
- PY 2024
Volume peers
Nearest volume peer: Sanofi-Aventis U.s. LLC ($10.7M)
Ortho-Clinical Diagnostics, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Ortho-Clinical Diagnostics, Inc.'s CMS-reported General Payments increased by $1.0M (+888.2%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: ORTHO-CLINICAL DIAGNOSTICS, INC.PY2023: ORTHO-CLINICAL DIAGNOSTICS, INC.PY2024: Ortho-Clinical Diagnostics, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $115,276.84
- PY2024
- $1,139,174.94
What the Data Shows for Ortho-Clinical Diagnostics, Inc.
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For Ortho-Clinical Diagnostics, Inc., that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
"Consulting Fee" leads the 6-category general-payment breakdown below at $679.4K (59.6% of General Payments, 18 transactions) - see our methodology for how research and ownership payments are reported separately.
General Payment Breakdown by Type
Ortho-Clinical Diagnostics, Inc. made 6 types of general payments. "Consulting Fee" is the largest category at $679.4K, 59.6% of General Payments.
Ortho-Clinical Diagnostics, Inc. reports 6 general-payment categories - the top three are Consulting Fee (59.6%), Compensation for Services Other Than Consulting (29.9%), and Royalty or License (4.4%). The remaining 3 categories make up 6.0% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Ortho-Clinical Diagnostics, Inc. divides its payments
General-payment categories, ordered by reported total
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $679.4K | 18 | 59.6% |
| Compensation for Services Other Than Consulting | $340.9K | 24 | 29.9% |
| Royalty or License | $50.2K | 7 | 4.4% |
| Debt Forgiveness | $35.7K | 12 | 3.1% |
| Travel and Lodging | $23.5K | 10 | 2.1% |
| Food and Beverage | $9.5K | 161 | 0.8% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $968,354.18 (85.0%) of $1,139,174.94 in this company's General Payments records across 170 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Ortho-Clinical Diagnostics, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Kenneth Widder
$328,512.92 across 3 reported transactions
- 2
Mary Polan
$314,827.75 across 3 reported transactions
- 3
Uhs Hospitals
$243,190.00 across 9 reported transactions
- 4
Strong Memorial Hospital
$47,167.60 across 3 reported transactions
- 5
Paul Olivo
$34,655.91 across 13 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Ortho-Clinical Diagnostics, Inc. ranks #162 of 1,925 by total payments (top 8% by spend) but spreads that money notably more broadly than its spend rank alone would suggest -- #733 of 1,838 by HHI (top 40% most concentrated), a wider distribution than most similarly sized payers.
View all 12 companies in this HHI neighborhood as a list
- Route 92 Medical, Inc. : $704.7K total payments, HHI 2140
- Braintree Laboratories, Inc. : $652.0K total payments, HHI 2132
- elliquence, LLC : $336.3K total payments, HHI 2127
- Tosoh Bioscience, Inc. : $290.85 total payments, HHI 2118
- Meridian Bioscience Inc. : $173.7K total payments, HHI 2110
- Alaska Medical Technologies, Llc : $3.2K total payments, HHI 2108
- Ortho-Clinical Diagnostics, Inc. (this company) : $1.1M total payments, HHI 2099
- Endeavor Orthopaedics LLC : $427.85 total payments, HHI 2098
- MediView XR, Inc. : $31.1K total payments, HHI 2083
- Inquis Medical, Inc. : $58.0K total payments, HHI 2081
- Nexus Spine, LLC : $35.1K total payments, HHI 2077
- Integer Holdings Corporation : $54.0K total payments, HHI 2076
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Ortho-Clinical Diagnostics, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Ortho-Clinical Diagnostics, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Ortho-Clinical Diagnostics, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
TG Therapeutics, Inc.
Lexicon Pharmaceuticals, Inc.
Astellas Pharma US Inc
Alafair Biosciences, Inc.
Glaukos Corporation
Put this to use
Ortho-Clinical Diagnostics, Inc. ranks #162 of 1,925 by all-tracks total payments, led by "Consulting Fee".
- See where Ortho-Clinical Diagnostics, Inc. sits among every top spender on the full leaderboard. Top 100 by total payments
- Compare "Consulting Fee" spend across every manufacturer, not just Ortho-Clinical Diagnostics, Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.